cdmo.directory
← Compare landing

Dr. Reddy's Laboratories vs Grifols Partnership

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/drreddys/grifols

CategoryDr. Reddy's LaboratoriesGrifols Partnership
Listed sitecdmocdmo
SummaryIntegrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing.CDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.
Services
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Cell Therapy Manufacturing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Stability Testing & Storage
  • Quality Control Testing
  • Oral Solid Dosage Manufacturing
  • Formulation Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Process Development
  • Small Molecule Development & Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Biologics (Other)
  • Small Molecule
Indications
  • Oncology
  • Immunology
  • Metabolic
  • Infectious Disease
  • Respiratory
  • Gastroenterology
  • Women's Health
  • Immunology
  • Neurology
  • Cardiovascular
  • Infectious Disease
  • Respiratory
Locations
  • Headquarters, India
  • Global Headquarters, India
  • Americas, Americas
  • Europe, Europe
  • Asia, Asia
  • Australia, Oceania, Australia
  • Africa, Africa
  • Global Headquarters, Hyderabad, Telangana, India
  • Global presence, Multiple (66 countries)
  • Headquarters, Sant Cugat del Vallès, Catalonia, Spain
Certifications
  • DCGI · Identifier: DCGI-approved
  • USFDA · Identifier: USFDA-approved
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.